Clinical Observation of Erythropoietin in Treating the Malignant Tumour Anemia
-
Graphical Abstract
-
Abstract
Objective To observe the effect of recombinant human erythropietin ( rHuEpo) in t reating malignant tumour anemia (MTA) . Methods Thirty cases of treated group were treated with rHuEpo 10000 U, qod, lasted for 8 weeks . Thirty cases of control group were treated with support cares and the blood transfusion. Results The overall response rates of treated and control group were 73. 3 %(22/30) and 13. 3 % (4/ 30) respectively, and the increased Hb of treated group is more higher than that of control group ( P < 0. 01) . Conclusion rHuEpo is effective and safe in treating MTA.
-
-